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Background For many women, the need for multiple clinical visits
is a barrier to medical abortion.
Objectives We assessed the effectiveness, safety, and acceptability
of self-assessment of the outcome of medical abortion completed
at home versus routine clinic follow up after medical abortion.
Search strategy We searched databases such as MEDLINE,
Embase, and CENTRAL to find studies published in 1991–2018.
Selection criteria Eligible studies included women of reproductive
age who had undergone a medical abortion that was completed at
home. The intervention and self-assessment of the outcome of
medical abortion done by urine pregnancy tests kits by women at
home was compared with routine medical follow up at a clinic.
Data collection and analysis Two researchers completed the study
selection, data extraction, critical appraisal, and assessment of the
evidence. The outcomes were successful complete abortions, side
effects and complications, and acceptability. We performed meta-
analyses when possible and GRADE to ascertain the certainty of
the evidence. The protocol was registered in PROSPERO
(CRD42017055316).
Main results Four randomised controlled trials (RCTs; n = 5493)
met our inclusion criteria. The pooled analysis from all studies
showed no significant difference in complete abortion rates
between self-assessment and routine clinic follow up: RR = 1.00,
95% CI 0.99–1.01. The ongoing pregnancy rates were similar and
the pooled results for the safety outcomes showed no significant
differences between the groups. There was a significantly greater
preference for self-assessment as the follow-up method.
Conclusions The effectiveness, safety, and acceptability of self-
assessment of the outcome of medical abortion completed at
home are not inferior to routine clinic follow up.
Keywords Abortion, home, pregnancy test, self-assessment,
systematic review.
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Introduction
Medical abortion is increasingly being used for early termi-
nation of pregnancy.1 The World Health Organization
(WHO) recommends the mifepristone–misoprostol combi-
nation regimen for medical abortion2,3 because it works fas-
ter than a misoprostol-only regimen and is approximately
98% effective up to 9 weeks (63 days) of gestation.4,5 It can
be performed either at a clinic or at home,6 providing
women with options based on their choice.7
Despite excellent effectiveness and safety, the procedure
remains inaccessible for many women, especially in low-
resource settings.6,8 The required clinic follow-up visit to
ensure the termination of pregnancy in medical abortion is
one of the most important barriers affecting access and
acceptability. Many women, especially those with low
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autonomy and limited financial resources, perceive clinic
visits as burdensome, and the long travel time required for
clinic visits results in lost wages and difficulties in ensuring
privacy.6 Administration of misoprostol at home and sub-
sequent self-assessment of the outcome of the abortion help
to de-medicalise abortion and provide more privacy to
women. The assessment to detect the absence of ongoing
pregnancy can be performed by health personnel at a clinic
or can be self-assessed by women themselves at home with
a Urine Pregnancy Test (UPT) kit, typically a Low Sensitiv-
ity Urine Pregnancy Test (LSUPT), Semi-Quantitative
Urine Pregnancy Test (SQUPT) or High Sensitivity Preg-
nancy Test (HSPT).7
Recently, studies have shown that the self-assessment of
outcome of medical abortion done by UPT kits with a fol-
low-up telephone call, text message or online conversation
can be an alternative to clinical follow up after medical
abortion. A study has shown that a telephone follow up
with self-test is a feasible and accurate method of determin-
ing the outcome of medical abortion.9 While evidence
seems to support the benefits of self-assessment of the out-
come of medical abortion, efforts are needed to optimise
clinical recommendations for self-assessment compared
with routine clinic follow-up visits. The objective of this
systematic review was to assess the effectiveness, safety, and
acceptability of self-assessment of the outcome of medical
abortion compared with routine clinic follow up after med-
ical abortion at home.
Methods
We conducted a systematic review in accordance with the
Cochrane Handbook for Systematic Reviews of Interven-
tions,10 with at least two researchers involved in the study
selection, data extraction, assessment of risk of bias (RoB)
of the included studies, data extraction, and Grading of
Recommendations Assessment, Development, and Evalua-
tion (GRADE). The study protocol was registered a priori
in PROSPERO (CRD42017055316).11 Patients were not
involved in the development of the review.
Search strategy and selection criteria
We collaborated with two search librarians in developing
the search strategy, which incorporated subject headings
and text words, in title and abstract, for ‘Abortion’ AND
‘Pregnancy Test’ AND ‘Home’ (the full search strategy is
available in Appendix S1). In February 2018, we searched
in the following databases: MEDLINE, Embase, Cochrane
Central Register of Controlled Trials, Web of Science,
Cumulative Index to Nursing and Allied Health Literature,
British Nursing Index and Archive, Scopus, and Google
Scholar. We searched from year 1991 up to February 2018
because medical abortion with mifepristone and
prostaglandin was licensed for the ending of pregnancy up
to 9 weeks of gestational age in 1991.12,13 We filtered the
search to identify studies on humans in English language.
We also searched in ClinicalTrials.gov and WHO Interna-
tional Clinical Trials Registry Platform for ongoing studies.
Further, we screened the reference lists of systematic
reviews and literature reviews to identify any other relevant
publications.
Studies eligible for inclusion were randomised controlled
trials (RCTs) and, in the event we had not identified high-
quality RCTs, also non-RCTs, interrupted-time-series, con-
trolled before/after studies, and prospective cohort studies
with a control group. The population was women of repro-
ductive age (≥15 years) who had a confirmed pregnancy,
the confirmation of which was done by ultrasound, clini-
cally, or by a positive urine or serum human chorionic
gonadotropin (hCG) test, and who had requested a medical
termination of pregnancy up to 9 weeks of gestation age,
which they performed at home (i.e. mifepristone was
administered in the clinic, whereas the women adminis-
tered misoprostol at home and expelled the embryo at
home). The intervention was self-assessment of the abor-
tion outcome done using UPTs such as LSUPT, SQUPT or
HSPT by women themselves at home, combined with a fol-
low up by home visit or telephone call or a combination of
these to confirm the complete termination of pregnancy.
Self-assessment by women at home was compared with
assessment by medical/healthcare personnel during routine
clinic follow-up visit. Our primary outcome was successful
complete abortion, i.e., complete evacuation of the uterine
contents with no requirement for surgical or repeat medical
intervention within 3 months of complete abortion. The
secondary outcomes were medical abortion failure such as
ongoing pregnancy14 and/or side effects and complications,
such as pain, haemorrhage (excessive bleeding), endometri-
tis, gastrointestinal side effects (e.g. nausea, vomiting, diar-
rhoea), headache, dizziness, and thermoregulatory changes,
loss to follow up, number of clinic visits or number of tele-
phone consultations, and acceptability of the technique.
We excluded studies conducted retrospectively. We also
excluded clinical practice guidelines, conference abstracts
and proceedings, books, chapters, animal and modelling
studies, reviews, protocols, and publications containing
only qualitative information or written in a language other
than English.
We imported the results from all the searches into END-
NOTE X8 to manage bibliographies and remove duplicates.
Next, screening of literature was carried out in a two-stage
procedure whereby each level consisted of increasing scru-
tiny of the studies based on the inclusion criteria of the
systematic review. The reviewers (N.B., R.B., F.D.) indepen-
dently assessed all titles and abstracts first, and then the full
texts of the potentially relevant studies. At each level, the
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authors compared their judgements and excluded studies
that did not meet all inclusion criteria. The reviewers
were not blinded to the authors or other information
about the publication when assessing the studies. We
recorded the reasons for exclusion of full texts (Table S1).
Two independent reviewers (N.B., F.D.) extracted data
from the published sources using a pre-designed data
recording form, related to setting, population, interven-
tion, comparator, and outcomes. Differences in opinion in
either the screening or data extraction processes were few
and were resolved by re-examination of the publication
and consensus; no authors had to be contacted. Two
independent reviewers (N.B., A.C.) appraised the included
studies using the Cochrane RoB tool,10 independently and
then jointly.
Data analysis
All outcomes were dichotomous and we estimated effect by
the relative risk (RR) and 95% confidence interval (CI).
We also decided, a priori, if studies were sufficiently simi-
lar, to pool those that could be grouped together and use
the statistical technique of meta-analysis to estimate effect,
using REVIEW MANAGER 5.3 (RevMan 2014). We used
Mantel–Haenszel random effects meta-analysis for dichoto-
mous outcomes and examined between-study heterogeneity
with the chi-square (v2) test and I-square (I2) statistic.
Lastly, to assess the certainty of the evidence, we performed
a GRADE assessment for the primary outcome and selected
secondary outcomes.15,16
Results
The search resulted in 1478 individual records (Figure 1).
After screening the titles and abstracts, we obtained and
read the full text for 132 publications, of which four studies
(presented in five publications) met the inclusion criteria
(Table 1).6,7,17–19
Our RoB assessment of the included studies shows that
all studies had low risk of bias in all the domains except
for two domains with unclear risk (blinding of participants,
blinding of outcome assessment) (Figure 2). Because we
deemed the risk of bias to vary across outcomes, we
assessed biological outcomes separately from self-reported
outcomes (Figure S1, Table S2).
The four included studies were carried out between 2010
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Figure 1. PRISMA flow diagram for selection of studies for the systematic review.
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Vietnam,17 Moldova and Uzbekistan,19 and Austria, Fin-
land, Norway, and Sweden7 (Tables 1 and S2). All four
included studies were RCTs, with two classifying their stud-
ies as a non-inferiority RCT.6,7 In total, 5493 women, with
a mean age of about 27 years, were randomised. The inter-
vention in all studies was self-assessment with a pregnancy
test (LSUPT or SQUPT) in combination with a pictorial
instruction sheet, symptom checklist or no checklist. Follow
up was 1–3 weeks later by telephone call7,17,19 or 2 weeks
by home visit or telephone call.6 In all studies, the compar-
ison was routine medical follow up at a clinic. All reported
on successful complete abortions, ongoing pregnancy,
safety,6,7,17,19 and acceptability.7,17–19
All four studies included the same primary outcome and
were sufficiently similar to warrant pooling of effect sizes
in a meta-analysis. Likewise, we could pool individual
study results for ongoing pregnancy and safety outcomes.
Study results that could not be combined in meta-analyses
are shown in Tables S4–S6. The tools for assessing the
main outcome at home and measurement techniques at
clinics varied across studies.6,7,17,19 Thus, we used random
effect models.
Table 1. Characteristics of the included studies (n = 4)
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Effectiveness
Effectiveness was measured in terms of complete termina-
tion of pregnancy. The meta-analysis result showed there
was no statistical significant difference between self-assess-
ment and routine clinic follow up regarding complete ter-
mination of pregnancy (RR = 1.00, 95% CI = 0.99–1.01;
I2 = 0%) (Figure 3). Our GRADE assessment for the pri-
mary outcome found there was high certainty of the evi-
dence (Table S3).
Safety
The studies reported on ongoing pregnancy and safety in
terms of need for surgery, occurrence of haemorrhage,
occurrence of fever and infections, and rates for drug
administration for haemorrhage. Operationalisations of
safety outcomes were not given in the study publications
(Table S2). We were able to conduct meta-analyses for four
safety outcomes. There were no statistically significant
differences between the two groups with regard to need for
surgery (RR = 0.92, 95% CI = 0.70–1.21, I2 = 0%), occur-
rence of haemorrhage (RR = 1.48, 95% CI = 0.84–2.60,
I2 = 43%), fever and infections (RR = 0.41, 95% CI = 0.08–
2.12, I2 = 62%), rates of drug administration for haem-
orrhage (RR = 1.80, 95% CI = 0.60–5.39, I2 = 0%) or
ongoing pregnancy (RR = 0.90, 95% CI = 0.50–1.62,
I2 = 7%) (Figure 4). Drugs administered for haemorrhage
were intravenous fluids, blood transfusion, and iron supple-
ments (Table S2). Our GRADE assessments for these sec-
ondary outcomes found that the certainty in the safety
estimates ranged from moderate to low (Table S3). Out-
comes on safety reported in only one study could not be
pooled and are reported in Table S4. There were no statisti-
cally significant differences between the self-assessment
group and the routine clinic follow-up group with regard to
these safety outcomes (need for blood transfusion, admission
to hospital, pain, additional phone consultation, clinic visit).
Figure 2. Risk of bias (RoB) assessment graph: Review authors’ judgements about each RoB item presented as percentages across all included
studies.
Figure 3. Forest plot, effectiveness of the outcome of medical abortion (complete termination of pregnancy). Self-assessment of the outcome of
medical abortion at home was compared with routine clinic follow up.
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Acceptability of self-assessment
Acceptability was measured in terms of preference for
assessment in the event of a future medical abortion. All
four studies found that the acceptability of follow-up tech-
nique was significantly greater for self-assessment than for
routine clinic follow up (Table S5).
Our final outcome of interest was loss to follow up. The
percentage of women lost to follow up was slightly lower




In this systematic review of four well-conducted RCTs, we
found that for both effectiveness and safety, self-assessment of
the outcome of medical abortion at home is not inferior to
routine clinic follow up. There is high-quality evidence that
complete abortion rates do not differ between the two condi-
tions. The meta-analyses results also showed that there are no
serious complications related to self-assessment at home and
ongoing pregnancy rates are not higher compared with clinic
follow up. With moderate- to low-quality evidence for the
safety outcomes, self-assessment at home appears to be as safe
as routine clinic follow up. Furthermore, our results shed
light on the acceptability of follow-up method, showing that
the preference of follow-up technique is significantly greater
for self-assessment than for routine clinic follow up.
Strengths and limitations
We conducted the review in accordance with the criteria in
the Cochrane Handbook for Systematic Reviews of
Figure 4. Forest plot, ongoing pregnancy, and safety of the outcome of medical abortion (need for surgery, haemorrhage, fever and infections, drug
administration for haemorrhage). Self-assessment of the outcome of medical abortion at home was compared with routine clinic follow up.
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Interventions. The searches covered a range of databases
and ran up to February 2018. We conducted meta-analyses
and assessed the certainty of the evidence. We could not
statistically assess the possibility of publication bias because
of the low number of included studies. However, it is unli-
kely that studies have been missed, as a thorough search
was performed in different databases. Similarly, although
the meta-analyses revealed moderate heterogeneity for the
safety outcomes, we could not explore reasons for hetero-
geneity through sub-group analyses because of the low
number of studies included. Due to a lack of resources,
publications in languages other than English were not con-
sidered eligible. To the best of our knowledge, there is no
core outcome set for self-assessment of the outcome of
first-trimester medical abortion, thus we were inclusive in
our review outcomes. The definition of outcomes, includ-
ing treatment success, is a recognized problem in publica-
tions related to abortion.19 Despite these limitations, this
review is able to draw strong conclusions about the effec-
tiveness and safety of the outcome of assessment of medical
abortion at home.
Interpretation
Home self-administration of misoprostol for medical abor-
tion has been suggested to be safe, efficient, feasible, and
acceptable by a handful of studies from the USA.20–24 Stud-
ies have shown it to be highly acceptable and the majority
of women specified that they would prefer home adminis-
tration of medical abortion again in the hypothetical situa-
tion of needing another abortion.13 Women reported that
it is much easier to tolerate the side effects in the known,
comfortable environment of their homes with someone
familiar nearby to support them, which ultimately prepares
them for any problems that could arise later.25 Correct
diagnosis of ongoing pregnancy is an important aspect of
follow up after medical abortion. The Royal College of
Obstetricians and Gynaecologists (RCOG) in its recent
guidance has advised that telephone follow up and urine
pregnancy testing may be considered appropriate in the
absence of evidence to recommend one particular proce-
dure for routine follow up to exclude ongoing pregnancy
after medical abortion.9 Although ultrasound examination
is the only sure way to confirm ongoing pregnancy, our
review results support the RCOG recommendation, as the
rates of complete abortion, ongoing pregnancy, and other
complications were similar irrespective of whether the
assessment of outcome was performed by women them-
selves or healthcare professionals. Grossman et al.25 in their
review in 2010 stated that alternatives to routine in-person
follow-up visits after medical abortion, such as women’s
self-assessment without using any tests, clinician’s assess-
ment, serum hCG measurements, UPT, or a combination
of these techniques are accurate at diagnosing the complete
termination of pregnancy. However, the researchers empha-
sised that there is a need for additional research to deter-
mine the accuracy, acceptability, and feasibility of
alternative follow-up modalities in practice, particularly of
home-based urine testing with self-assessment.
To the best of our knowledge, our review is the first sys-
tematically to evaluate effectiveness, safety, and acceptabil-
ity of self-assessment of the outcome of medical abortion
at home compared with routine clinic follow up. Concern-
ing generalisability, Ngo et al.26 found that there was no
difference in effectiveness or acceptability and safety
between medical abortion performed at home and clinic
across countries, a finding that is supported by the results
on follow-up assessment in this review.
Conclusion
This review offers encouraging evidence of the effectiveness,
safety, and acceptability of self-assessment of the outcome
of medical abortion at home combined with telephone fol-
low up or home visit. It demonstrates that there is high-
quality evidence that the effectiveness of self-assessment of
the outcome of medical abortion at home is not inferior to
routine clinic follow up. It also shows that self-assessment
at home appears to be as safe as routine clinic follow up
and is preferred by women from both high- and low-re-
source countries.
In low-resource settings, where access to health facilities
or ultrasound examination is limited or abortion services
are socially sanctioned, the self-assessment of the outcome
of medical abortion with UPTs and a simple follow-up
technique such as a telephone call or home visit is a viable
option. Furthermore, in all resource settings, self-assess-
ment at home helps to shorten the waiting times for
patients and reduces the need for medical resources. It also
saves time and energy for women who travel, sometimes
long distances, to clinics, who have to arrange childcare or
take time off from household or work duties. Moreover,
this technique provides women with a confidential and
friendly environment to confirm the outcome of abortion
at home, and it may encourage women to access abortion
at an early gestational age (because they know there is no
clinic follow up), which helps to reduce risks and compli-
cations related to abortion at later gestational ages.
Although high-quality evidence is drawn from this
review, regarding especially the effectiveness of self-assess-
ment of abortion at home, researchers are encouraged to
conduct further research on different aspects of this topic
in various study areas. Studies should be conducted to
investigate the long-term safety outcomes of self-assessment
of the outcome of medical abortion, such as fertility, and
effectiveness and safety among vulnerable groups, such as
women living with HIV, teenagers, and immigrants.
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Likewise, studies should analyse reasons for follow-up pref-
erences among both women themselves and patients’ part-
ners or family members, as this would give a broader and
stronger evidence base concerning the attitude and accept-
ability of communities towards self-assessment.
There is a rapid rise in healthcare costs in the present
world. Therefore, it is essential that healthcare policy mak-
ers focus on developing interventions that are not only
effective but also cost-effective and affordable. Self-assess-
ment of medical abortion is one of the interventions that
may be both effective and affordable. However, due to
complete lack of economic evaluation in the included stud-
ies, it is impossible to draw any conclusions on the cost-
effectiveness of self-assessment. Thus, there is a clear need
for further research evaluating the economics of the assess-
ment.
In sum, self-assessment of the outcome of medical abor-
tion at home is a simple follow-up technique which is
comparable in effectiveness and safety to routine clinic fol-
low up, acceptable to women, and feasible to implement
regardless of resource settings, giving women the choice to
carry out the assessment themselves or in clinics. This does
not prevent women from selecting routine clinic follow up.
Rather, it gives women greater choice in abortion care,
facilitating access to safe and acceptable abortion options.
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